ADX-038

· ADARx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ADX-038, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease [Phase 2]